Small-dose propofol sedation attenuates the formation of reactive oxygen species in tourniquet-induced ischemia-reperfusion injury under spinal anesthesia

Ya Jung Cheng, Yong Ping Wang, Chiang Ting Chien, Chau Fong Chen

Research output: Contribution to journalArticle

76 Citations (Scopus)

Abstract

The release of a tourniquet produces reactive oxygen species (ROS), which can cause ischemia-reperfusion injury. We investigated the effects on ROS production in 22 adult ASA physical status I-II patients sedated with small-dose propofol infusion and IV midazolam undergoing elective total knee replacement under intrathecal anesthesia, allocated randomly to one of two groups. In the Propofol group, sedation was performed with propofol 0.2 mg/kg followed by infusion at a rate of 2 mg · kg-1·h-1. In the Control group, IV midazolam 5 mg was given. ROS production was measured by lucigenin chemiluminescence analysis. Blood samples were obtained from the radial artery after spinal anesthesia, I min before release of the tourniquet and 5 and 20 min after reperfusion. The ischemic time was approximately 70 min. ROS production decreased nonsignificantly before reperfusion in both groups but increased significantly 5 and 20 min after reperfusion in the Midazolam group. In the Propofol group, no significant increase of ROS production was found. We conclude that small-dose propofol infusion attenuates ROS production in tourniquet-induced ischemia-reperfusion injury.

Original languageEnglish
Pages (from-to)1617-1620
Number of pages4
JournalAnesthesia and Analgesia
Volume94
Issue number6
DOIs
Publication statusPublished - 2002 Jan 1

Fingerprint

Tourniquets
Spinal Anesthesia
Propofol
Reperfusion Injury
Reactive Oxygen Species
Midazolam
Reperfusion
Knee Replacement Arthroplasties
Radial Artery
Luminescence
Anesthesia
Control Groups

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Small-dose propofol sedation attenuates the formation of reactive oxygen species in tourniquet-induced ischemia-reperfusion injury under spinal anesthesia. / Cheng, Ya Jung; Wang, Yong Ping; Chien, Chiang Ting; Chen, Chau Fong.

In: Anesthesia and Analgesia, Vol. 94, No. 6, 01.01.2002, p. 1617-1620.

Research output: Contribution to journalArticle

@article{2a1b9601de1d40b4a8751c9728e49a20,
title = "Small-dose propofol sedation attenuates the formation of reactive oxygen species in tourniquet-induced ischemia-reperfusion injury under spinal anesthesia",
abstract = "The release of a tourniquet produces reactive oxygen species (ROS), which can cause ischemia-reperfusion injury. We investigated the effects on ROS production in 22 adult ASA physical status I-II patients sedated with small-dose propofol infusion and IV midazolam undergoing elective total knee replacement under intrathecal anesthesia, allocated randomly to one of two groups. In the Propofol group, sedation was performed with propofol 0.2 mg/kg followed by infusion at a rate of 2 mg · kg-1·h-1. In the Control group, IV midazolam 5 mg was given. ROS production was measured by lucigenin chemiluminescence analysis. Blood samples were obtained from the radial artery after spinal anesthesia, I min before release of the tourniquet and 5 and 20 min after reperfusion. The ischemic time was approximately 70 min. ROS production decreased nonsignificantly before reperfusion in both groups but increased significantly 5 and 20 min after reperfusion in the Midazolam group. In the Propofol group, no significant increase of ROS production was found. We conclude that small-dose propofol infusion attenuates ROS production in tourniquet-induced ischemia-reperfusion injury.",
author = "Cheng, {Ya Jung} and Wang, {Yong Ping} and Chien, {Chiang Ting} and Chen, {Chau Fong}",
year = "2002",
month = "1",
day = "1",
doi = "10.1213/00000539-200206000-00047",
language = "English",
volume = "94",
pages = "1617--1620",
journal = "Anesthesia and Analgesia",
issn = "0003-2999",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Small-dose propofol sedation attenuates the formation of reactive oxygen species in tourniquet-induced ischemia-reperfusion injury under spinal anesthesia

AU - Cheng, Ya Jung

AU - Wang, Yong Ping

AU - Chien, Chiang Ting

AU - Chen, Chau Fong

PY - 2002/1/1

Y1 - 2002/1/1

N2 - The release of a tourniquet produces reactive oxygen species (ROS), which can cause ischemia-reperfusion injury. We investigated the effects on ROS production in 22 adult ASA physical status I-II patients sedated with small-dose propofol infusion and IV midazolam undergoing elective total knee replacement under intrathecal anesthesia, allocated randomly to one of two groups. In the Propofol group, sedation was performed with propofol 0.2 mg/kg followed by infusion at a rate of 2 mg · kg-1·h-1. In the Control group, IV midazolam 5 mg was given. ROS production was measured by lucigenin chemiluminescence analysis. Blood samples were obtained from the radial artery after spinal anesthesia, I min before release of the tourniquet and 5 and 20 min after reperfusion. The ischemic time was approximately 70 min. ROS production decreased nonsignificantly before reperfusion in both groups but increased significantly 5 and 20 min after reperfusion in the Midazolam group. In the Propofol group, no significant increase of ROS production was found. We conclude that small-dose propofol infusion attenuates ROS production in tourniquet-induced ischemia-reperfusion injury.

AB - The release of a tourniquet produces reactive oxygen species (ROS), which can cause ischemia-reperfusion injury. We investigated the effects on ROS production in 22 adult ASA physical status I-II patients sedated with small-dose propofol infusion and IV midazolam undergoing elective total knee replacement under intrathecal anesthesia, allocated randomly to one of two groups. In the Propofol group, sedation was performed with propofol 0.2 mg/kg followed by infusion at a rate of 2 mg · kg-1·h-1. In the Control group, IV midazolam 5 mg was given. ROS production was measured by lucigenin chemiluminescence analysis. Blood samples were obtained from the radial artery after spinal anesthesia, I min before release of the tourniquet and 5 and 20 min after reperfusion. The ischemic time was approximately 70 min. ROS production decreased nonsignificantly before reperfusion in both groups but increased significantly 5 and 20 min after reperfusion in the Midazolam group. In the Propofol group, no significant increase of ROS production was found. We conclude that small-dose propofol infusion attenuates ROS production in tourniquet-induced ischemia-reperfusion injury.

UR - http://www.scopus.com/inward/record.url?scp=0036262185&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036262185&partnerID=8YFLogxK

U2 - 10.1213/00000539-200206000-00047

DO - 10.1213/00000539-200206000-00047

M3 - Article

C2 - 12032039

AN - SCOPUS:0036262185

VL - 94

SP - 1617

EP - 1620

JO - Anesthesia and Analgesia

JF - Anesthesia and Analgesia

SN - 0003-2999

IS - 6

ER -